BSE filing, NSE: COCKERILL. Summary written from the filing by ALFA Finder's alert engine.
John Cockerill India Ltd: key numbers
- Share price
- ₹6,861.75
- Market cap
- ₹3,388 Cr
- Revenue (annual)
- ₹357.6 Cr
- Net profit (annual)
- ₹10.31 Cr
- P/E (TTM)
- 287.8×Sector 51.7×
- Promoter holding
- 70.44%+0.00% QoQ
- FII holding
- 0.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from John Cockerill India Ltd
All →John Cockerill India Other Announcement
John Cockerill India Limited filed its Regulation 74(5) certificate for the quarter ended September 30, 2026, confirming no dematerialization requests were received.
John Cockerill India Management Change
John Cockerill India Limited announced the resignation of Mr. Vivek Mukund Bhide from his position as Non-Executive Non-Independent Director, effective September 15, 2026.
John Cockerill India Bags ₹200 Cr Order
John Cockerill India Ltd secured a Rs. 200 Crore contract from A1 Iron & Steel Tanzania Ltd for supply and installation of industrial equipment. The project spans ten months.
- Value
- ₹200.0 Cr
- Execution
- 10 months from August 2026
John Cockerill India Earnings Call Transcript: Key Takeaways
Management projects confidence via a massive 4,500 Cr order book while navigating transitional costs from global entity consolidation. Revenue fell sequentially due to project lifecycles, but YoY growth remains robust.
John Cockerill India Management Change
John Cockerill India Limited appointed Deepak Prabhakar Chindarkar as Chief Financial Officer, effective August 24, 2026. He brings over 36 years of finance leadership experience.
John Cockerill India Investor Presentation: Key Takeaways
John Cockerill India (JCIL) reported strong YoY standalone revenue growth of 82% in Q2 CY26. Consolidation of Chinese, German, and Belgian entities marks a strategic shift towards an integrated global platform.
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.